All In Biotech

Drug Trial Radar · NCT07254286

Food Effect Study in Healthy Volunteers

A Phase 1 Open-Label, Randomized, Crossover Food Effect and Formulation Assessment for Icovamenib Capsule in Healthy Volunteers

Last checked: Nov 19, 2026Latest source record: Feb 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

60

Actual

Start

Sep 11, 2025

Primary completion

Jan 14, 2026

Study completion Jan 14, 2026

Sponsor

Lead sponsor
Biomea Fusion Inc.Industry
Sponsor type
Industry
First posted
Nov 28, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A phase 1 open-label, randomized, crossover food effect and formulation assessment for icovamenib capsule in healthy volunteers.

Conditions

  • Healthy Volunteer

Interventions

  • IcovamenibDrug

    Investigational Product

  • Icovamenib HPMCDrug

    Investigational Product

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluate food effect and PK profile of icovamenib capsule formulation in fed and fasted statesTime frame: Every other day for a max of 2 weeks
  2. Evaluate food effect and PK profile of icovamenib capsule formulation in fed and fasted statesTime frame: Every other day for a max of 2 weeks
  3. Evaluate food effect and PK profile of icovamenib capsule formulation in fed and fasted statesTime frame: Every other day for a max of 2 weeks
  4. Evaluate food effect and PK profile of icovamenib capsule formulation in fed and fasted statesTime frame: Every other day for a max of 2 weeks
  5. Evaluate food effect and PK profile of icovamenib capsule formulation in fed and fasted statesTime frame: Every other day for a max of 2 weeks
  6. Evaluate food effect and PK profile of icovamenib capsule formulation in fed and fasted statesTime frame: Every other day for a max of 2 weeks
  7. Evaluate food effect and PK profile of icovamenib capsule formulation in fed and fasted statesTime frame: Time Frame: Every other day for a max of 2 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Quotient Sciences - Miami, Inc.

    Miami, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.